Clinical Trial Update: RSYR for Fatigue Reduction in Cancer Survivors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on RSYR for reducing fatigue in cancer survivors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-related Fatigue in Cancer Survivors

Drugs mentioned

• RSYR

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Cancer-related Problem/Condition | Phase 2 | Status: COMPLETED